Copper
Essential trace mineral
Also known as zinc + copper, zinc and copper, copper bisglycinate, copper gluconate, cupric, copper sulfate
On this shelf because of zinc. High-dose zinc blocks copper absorption; the deficiency that follows brings anemia, low white cells and nerve damage that may not reverse. Audits find most zinc patients never get checked. Whether a healthy man needs extra copper is another matter.
What doses have been studied? What each trial gave, with the population it was given to.
Overview
In shortCopper is here because of zinc. Taking a lot of zinc blocks copper absorption, and the deficiency that follows causes anemia, low white cells and, at worst, spinal cord damage that only partly recovers. That is why zinc + copper products exist. This page is about where the risk starts, how often it is missed, and whether adding copper is the fix.
Copper is an essential trace mineral the body uses to make hemoglobin, run cellular respiration, build connective tissue and defend against oxidation. Deficiency is rare on a normal diet. It becomes common in one situation this forum cares about: taking zinc.
Zinc and copper compete for absorption in the gut, and sustained high zinc intake induces an intestinal protein that traps copper and lets it pass out with shed cells. The result is acquired copper deficiency, which presents as anemia, low neutrophils, and in the worst cases a spinal cord syndrome that mimics B12 deficiency and only partly recovers. Supplement makers sell "zinc + copper" products to pre-empt this. This page is about what the evidence says on the risk, the dose where it starts, and whether adding copper is the answer.
Mechanism
In shortZinc and copper compete in the gut. High zinc switches on a protein in the gut lining that grabs copper and carries it out with shed cells, so less copper reaches the blood. The earliest sign is a drop in a copper-dependent enzyme in red cells, which in men showed up after six weeks at 50 mg of zinc a day, before blood copper itself moved.
Dietary copper enters intestinal cells through the Ctr1 transporter and leaves them into the blood through the ATP7A pump. Zinc interferes upstream: high zinc intake induces metallothionein in the intestinal lining, a protein that binds copper more avidly than zinc, so copper is held in the cell and lost when the cell is shed. Copper absorption falls, serum copper and ceruloplasmin fall, and copper-dependent enzymes lose activity.
The enzyme the trials watch is erythrocyte copper-zinc superoxide dismutase, a more sensitive marker of copper status than serum copper. In a six-week trial in men, 50 mg of zinc a day left serum copper and ceruloplasmin unchanged but lowered that enzyme's activity, which is how a falling copper status looks before it becomes a deficiency.
Evidence
In shortTrials put the threshold around 50 mg of zinc a day; 15 to 30 mg for six months did not shift copper status. An audit of 70 zinc-prescribed patients found 62% on risky doses and copper checked in only two. In a Japanese adverse-event database, 3.8% of 2,646 zinc patients were reported copper deficient, onset around 137 days. No trial shows that adding copper prevents this in healthy people.
Where the dose starts to matter. Three controlled trials bracket it. In healthy men, two daily doses of 25 mg of zinc for six weeks significantly lowered erythrocyte superoxide dismutase, suggesting reduced copper status. In healthy French adults aged 55 to 70, 15 or 30 mg of zinc a day for six months raised serum zinc but did not change copper status. In healthy boys aged 6 to 8, 5 to 15 mg a day for four months changed neither the traditional markers nor the sensitive ones. The signal appears around 50 mg a day and is absent at 30 mg in these short trials; longer exposure at moderate doses is not well studied.
How often it is missed. A 2015 audit of 70 patients prescribed zinc found 62% were on doses sufficient to cause copper deficiency, plasma copper was measured in only two of them, 9% developed unexplained anemia and 7% neurological symptoms typical of copper deficiency. A 2023 review of a Scottish trace-element laboratory's records found 14 confirmed cases of zinc-induced copper deficiency, half of them previously undiagnosed, and recommended revising official zinc dosing advice. A 2026 analysis of Japanese adverse-event reports found copper deficiency reported in 3.8% of 2,646 patients on oral zinc, with each extra milligram per kilogram per day multiplying the odds 3.5-fold, a median onset of 137 days, and chronic kidney disease the strongest risk factor.
What deficiency does. A review of 55 published cases of copper deficiency myelopathy found cytopenias in 78%, abnormal spinal MRI in 47%, and zinc overload, prior upper gastrointestinal surgery and malabsorption as the risk factors. Treatment with copper normalized the blood counts; neurological recovery was partial at best. A hematology review puts blood-count recovery at four to twelve weeks of copper replacement, with neurological signs only partly reversible. Three case reports in men aged 21 to 47 describe anemia, severe neutropenia and progressive neuropathy, all traced to zinc excess after bone marrow examination.
What is not shown. No trial on this page tests whether taking copper alongside zinc prevents the problem in healthy people, and no trial shows a benefit of added copper for a man who is not deficient. The combined products are a plausible precaution, not an evidenced one.
Safety
In shortCopper is toxic in excess, with a narrower margin than zinc, and anyone with Wilson's disease must avoid it. The bigger risk on this forum is the reverse: months of zinc at 50 mg a day or more can quietly cause copper deficiency, and the nerve damage may not reverse. Serum copper, ceruloplasmin and a blood count catch it early.
Copper itself is toxic in excess, and the margin is narrower than for zinc: acute overdose causes vomiting and liver injury, and nutrition authorities publish an upper limit for that reason. Nobody with Wilson's disease, a genetic copper-storage disorder, should take copper. A trial in women found copper given with vitamin C inhibited non-heme iron absorption at high copper-to-iron ratios, so copper is not a free addition to a mineral stack.
The safety point that matters most on this forum runs the other way. If you take zinc at 50 mg a day or more for months, for colds, for testosterone, for skin, the risk is copper deficiency, and its early signs, fatigue and easy infections from anemia and low neutrophils, are easy to blame on something else. The nerve damage that follows may not reverse. Serum copper and ceruloplasmin are cheap tests; a full blood count catches most cases earlier.
Regulatory status
In shortA supplement and food additive in the US, UK and EU, with a recommended intake, an upper limit, and no approved claims. Treating a deficiency is a medical decision made on blood tests, not a shelf purchase.
A dietary supplement and a food additive in the United States, the United Kingdom and the European Union, with a published recommended intake and tolerable upper intake level, and no approved claims. Copper deficiency is treated with copper gluconate, sulfate or chloride, orally or intravenously, as a medicine; that is a clinical decision made on blood tests, not a supplement choice.
The literature
9 studies indexed. Findings and limitations get equal weight, on purpose.
Members area
The Copper literature needs an account
Everything above is free to read. What an account opens is the evidence underneath it: 9 studies with their limitations, and the regimen each trial actually reported.
- Every study, with what it found and what it cannot show
- The limitations, given the same weight as the findings
- The dose each named trial administered, where recorded
Free to create. A membership is separate, and you can decide about that later.
Reading is free, an account is not the same as paying. 80 compound guides, every study with its limitations written underneath, and the regimens those trials actually used. A free account opens all of it. A membership is a separate decision, and it opens the forum. What membership costs.
The wider literature
14 indexed papers and 14 registered trials mentioning Copper, straight from PubMed and ClinicalTrials.gov. 7 of 14 administer it; the rest measure it. These have not been read by us. Unlike the studies above, they carry no findings and no limitations written by anyone here, because writing either would mean claiming a reading nobody has done. They are a starting point for yours.
Registered trials (14)
- A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
City of Hope Medical Center2026NCT07619599
interventionalphase1recruitingn=6
- Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety
American Regent, Inc.2025NCT05661682
interventionalphase4withdrawnn=0
- Clinical Performance of the I-arch System During the Initial Stage of Orthodontic Treatment
Tabark H. Omran2025NCT07264127
interventionalnarecruitingn=34
- Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN
American Regent, Inc.2024NCT05677126
interventionalphase4withdrawnn=0
- Real World Evidence Study in Subjects With Wilson's Disease
Orphalan2023NCT05783687
observationalcompletedn=50
- Micronutrient Status Involved in Immunity in Elderly Patients With COVID-19
Hospices Civils de Lyon2020NCT04877509
observationalcompletedn=229
- Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal
Assiut University2019NCT03600064
interventionalnacompletedn=80
- The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies
Poznan University of Life Sciences2016NCT03465462
interventionalnacompletedn=105
- LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
CDA Research Group, Inc.2014NCT02197182
interventionalearly_phase1terminatedn=50
- Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Al-Neelain University2011NCT01319734
interventionalphase1unknownn=50
- Safety Study of High Doses of Zinc in ALS Patients
Phoenix Neurological Associates, LTD2010NCT01259050
interventionalphase1phase2completedn=10
- Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease
Adeona Pharmaceuticals2009NCT01099332
interventionalphase1phase2unknownn=60
- Zinc and Copper Absorption in Neonates With Bilious Losses
Baylor College of Medicine2008NCT00738283
observationalcompletedn=17
- Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism
Milton S. Hershey Medical Center2006NCT00325572
interventionalphase1terminatedn=89
Papers (14)
- Iron, Zinc, Copper, Cadmium, Mercury, and Bone Tissue.
Ciosek Ż, et al.International journal of environmental research and public health2023PMID 36767564
journal articlereview
- Zinc and Copper Reduce Conjugative Transfer of Resistance Plasmids from Extended-Spectrum Beta-Lactamase-Producing Escherichia coli.
Buberg ML, et al.Microbial drug resistance (Larchmont, N.Y.)2020PMID 31951514
journal article
- Copper deficiency anemia: review article.
Myint ZW, et al.Annals of hematology2018PMID 29959467
journal articlereview
- Comparative toxicity of CuO nanoparticles and CuSO4 in rainbow trout.
Isani G, et al.Ecotoxicology and environmental safety2013PMID 23932511
journal articleresearch support, non-u.s. gov't
- Fate and toxicity of CuO nanospheres and nanorods used in Al/CuO nanothermites before and after combustion.
Kennedy AJ, et al.Environmental science & technology2013PMID 23971725
journal articleresearch support, non-u.s. gov't
- Diversity of dominant bacterial taxa in activated sludge promotes functional resistance following toxic shock loading.
Saikaly PE, et al.Microbial ecology2011PMID 21153808
journal articleresearch support, u.s. gov't, non-p.h.s.
- Decolorization and COD reduction of dyeing wastewater from a cotton textile mill using thermolysis and coagulation.
Kumar P, et al.Journal of hazardous materials2008PMID 17931773
journal article
- Monte Carlo simulation of electrodeposition of copper: a multistep free energy calculation.
Harinipriya S, et al.The journal of physical chemistry. B2008PMID 18324802
journal articleresearch support, non-u.s. gov't
- Metals in Alzheimer's and Parkinson's diseases.
Barnham KJ, et al.Current opinion in chemical biology2008PMID 18342639
journal articleresearch support, non-u.s. gov'treview
- Metals accelerate production of the aberrant splicing isoform of the presenilin-2.
Matsuzaki S, et al.Journal of neurochemistry2004PMID 15009634
journal articleresearch support, non-u.s. gov't
- Stimulation of oxygen evolution in photosystem II by copper(II) ions.
Burda K, et al.Zeitschrift fur Naturforschung. C, Journal of biosciences2002PMID 12440723
journal articleresearch support, non-u.s. gov't
- Zinc, copper and oxalocalcic urolithiasis.
Grases F, et al.Urologia internationalis1993PMID 8506591
journal articleresearch support, non-u.s. gov't
- Studies on the interaction of cupric isonicotinohydrazide with DNA.
Divakar S, et al.Biochemistry1987PMID 3651412
journal articleresearch support, non-u.s. gov't
- Effect of zinc, copper, and iron on ochratoxin A production.
Steele JA, et al.Applied microbiology1973PMID 4715563
journal article
Discussion
Copper has its own forum, and sits in Labs & Bloodwork. Every post says what kind of claim it makes.
Nobody has posted about Copper yet.
Membership
Supplements are free. The argument is for members.
The guide above is open to everyone, and the literature underneath it opens with a free account. That is the educational half of this site. Reading and joining the discussion around Copper, and every other entry, is what membership pays for.
For Research & Educational Discussion Only. Not Medical Advice
This guide is educational reference material compiled from published literature. It is not medical advice, not a recommendation, and not a substitute for a clinician who knows your history. Nothing here should be used to make a decision about your own health without one.
Talk to a licensed healthcare professional.